melanoma
75 проекта
H2020Индивидуална стипендия2020–2022Израел
MelImmuneOrg · Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy
H2020Индивидуална стипендия2020–2022Нидерландия
UNPACK PD-L1 · Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells
H2020Индивидуална стипендия2019–2021Дания
ARGONAUT · from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy
H2020Индивидуална стипендия2019–2021Белгия
INHuMAN · Intra-tumoral heterogeneity in NRAS-driven metastatic melanoma
H2020Индивидуална стипендия2018–2020Нидерландия
KILNEV · Killing Senescent Cells as a Novel Method to Eliminate Nevi
H2020Индивидуална стипендия2018–2020Дания
UTILIUM · Unraveling The Immune Landscape In Uveal Melanoma
H2020Индивидуална стипендия2018–2020Испания
IMMUNOMARK · Omics integration for precision cancer immunotherapy
H2020Индивидуална стипендия2018–2020Испания
CINK · Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers
H2020Индивидуална стипендия2018–2020Португалия
TRIBBLES · Characterizing the clinical relevance and the mechanism underlying TRIB2-mediated drug resistance to MEK inhibitiors in the context of melanoma
H2020Индивидуална стипендия2017–2021Испания
METMEL · Long range-acting drivers of premetastatic niches in melanoma
H2020Индивидуална стипендия2017–2019Ирландия
SAMNets · Investigation of adaptive design and rewiring of Survival-Apoptosis-Mitogenic (SAM) signalling transduction network
H2020Индивидуална стипендия2017–2019Израел
SCALTIE · Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy
H2020Обмен на изследователи2017–2023Испания
MAGNAMED · Novel magnetic nanostructures for medical applications
18 партньори · 8 държави
H2020Индивидуална стипендия2017–2018Испания
DLL4-LVN · Targeting the (pre)metastatic lympho-vascular niche: molecular mechanisms and therapeutic implications in melanoma
H2020Индивидуална стипендия2017–2019Франция
MCNTMTDC · Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours
H2020Индивидуална стипендия2016–2018Обединеното кралство
GENMETASTEM · GENOMIC AND METABOLIC REGULATION OF METASTATIC CANCER STEM CELLS
H2020Докторантска мрежа2015–2019Ирландия
TRAIN-ERS · Endoplasmic Reticulum Stress in Health and Disease
18 партньори · 11 държави
H2020Докторантска мрежа2015–2019Обединеното кралство
MELGEN · MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival
6 партньори · 5 държави
H2020Докторантска мрежа2015–2019Нидерландия
VIRION · Viruses, Immune stimulation and RNA Interference in Oncology Network
9 партньори · 4 държави
H2020Индивидуална стипендия2015–2017Дания
MatrixMacrophages · Matrix degrading macrophages in cancer growth and invasion
H2020Индивидуална стипендия2015–2017Обединеното кралство
MELANOPARK · Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells
H2020Индивидуална стипендия2015–2017Обединеното кралство
Tolltum · Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment
H2020Обмен на изследователи2014–2018Германия
SAGE-CARE · SemAntically integrating Genomics with Electronic health records for Cancer CARE
5 партньори · 5 държави
H2020Докторантска мрежа2014–2018Ирландия
MEL-PLEX · Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine
20 партньори · 11 държави
